In­vivyd says new Phase 3 da­ta on Covid an­ti­body sup­port pro­phy­lac­tic use

In­vivyd’s mon­o­clon­al an­ti­body can cut the risk of con­tract­ing Covid-19 in both healthy and im­muno­com­pro­mised peo­ple, ac­cord­ing to the lat­est ex­plorato­ry analy­sis from a Phase …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER